A PROTEOMIC CO-CLINICAL TRIAL OF BGJ-398 IN FGFR-DRIVEN BILIARY CANCERS

$235,429FY2017Department of the ArmyDOD

The General Hospital Corporation

Investigators

A PROTEOMIC CO-CLINICAL TRIAL OF BGJ-398 IN FGFR-DRIVEN BILIARY CANCERS · GrantIndex